๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay

โœ Scribed by Ian J. Stratford; Miriam A. Stephens

Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
459 KB
Volume
16
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Predictability of in vivo chemosensitivi
Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay
โœ Yutaka Shimoyama; Tetsuro Kubota; Masahiko Watanabe; Kyuya Ishibiki; Osahiko Abe ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 620 KB

The MTT assay reported by Mosmann is a rapid and convenient colorimetric assay for cellular growth and survival in vitro. In this paper, the MTT assay was modified as a chemosensitivity test, and its potential was investigated. Using 10 human tumor xenografts in athymic nude mice, the predictability

In vitro determination of cytotoxic drug
In vitro determination of cytotoxic drug response in ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA)
โœ Katalin Csรณka; Bengt Tholander; Eva Gerdin; Manuel de la Torre; Rolf Larsson; Pe ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 62 KB

The fluorometric microculture cytotoxicity assay (FMCA), a short-term in vitro assay based on the concept of total tumor cell kill, was used for testing the cytotoxic drug sensitivity of tumor cells from patients with ovarian carcinoma. A total of 125 fresh specimens was obtained, 98 (78%) of which

Histopathologic features of retinoblasto
Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay
โœ Antoinette Y. N. Schouten-van Meeteren; Paul van der Valk; Hans C. van der Linde ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 112 KB ๐Ÿ‘ 1 views

## BACKGROUND. Retinoblastoma is frequently treated with chemotherapy to facilitate intraocular therapy, as well as to diminish or delay radiotherapy in invasive disease. It is also used more extensively in patients with dissemination to the central nervous system and/or the bone marrow. Once the